We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
New Jersey Resources
NJR
$5.55B
| $5.57M | 0.01% |
126,024
-47,179
| -27% | -$2.12M |
|
|
SAFE
777
Safehold
SAFE
$1.08B
| $5.54M | 0.01% |
83,013
+73,858
| +807% | +$6.22M |
|
778
Truist Financial
TFC
$63.9B
| $5.54M | 0.01% |
120,258
+13,635
| +13% | +$672K |
|
|
ZEN
779
DELISTED
ZENDESK INC
ZEN
| $5.53M | 0.01% |
74,678
+52,773
| +241% | +$5.2M |
|
|
FISV
780
Fiserv Inc
FISV
$28B
| $5.51M | 0.01% |
62,460
-23,910
| -28% | -$2.32M |
|
781
Pinnacle Financial Partners Inc
PNFP
$16B
| $5.5M | 0.01% |
77,488
+58,370
| +305% | +$4.61M |
|
782
Mueller Industries
MLI
$15.1B
| $5.5M | 0.01% |
412,724
+24,748
| +6% | +$335K |
|
|
CLR
783
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.48M | 0.01% |
83,818
-38,997
| -32% | -$2.47M |
|
784
First Citizens BancShares
FCNCA
$25.4B
| $5.48M | 0.01% |
8,481
+30
| +0.4% | +$19.6K |
|
785
First Industrial Realty Trust
FR
$8.35B
| $5.46M | 0.01% |
116,196
+51,979
| +81% | +$2.85M |
|
786
Simpson Manufacturing
SSD
$8.19B
| $5.41M | 0.01% |
55,108
-26,964
| -33% | -$2.8M |
|
787
Steris
STE
$23.2B
| $5.38M | 0.01% |
26,182
+649
| +3% | +$146K |
|
788
Sonoco
SON
$5.71B
| $5.37M | 0.01% |
95,181
-183,442
| -66% | -$10.9M |
|
|
RYZ
789
Ryerson Holding Corp
RYZ
$1.44B
| $5.34M | 0.01% |
250,988
+150,038
| +149% | +$4.7M |
|
790
Vir Biotechnology
VIR
$1.51B
| $5.34M | 0.01% |
209,709
+100,139
| +91% | +$2.34M |
|
|
P
791
Everpure Inc
P
$36.4B
| $5.3M | 0.01% |
210,961
+23,161
| +12% | +$641K |
|
792
Service Corp International
SCI
$11.4B
| $5.3M | 0.01% |
76,893
-16,577
| -18% | -$1.13M |
|
793
Leidos
LDOS
$17.7B
| $5.26M | 0.01% |
53,084
+8,258
| +18% | +$856K |
|
794
Fortive
FTV
$18.6B
| $5.25M | 0.01% |
130,364
-259,852
| -67% | -$11.5M |
|
795
Ironwood Pharmaceuticals
IRWD
$711M
| $5.22M | 0.01% |
452,672
+481
| +0.1% | +$5.67K |
|
796
Trimble
TRMB
$13.5B
| $5.21M | 0.01% |
89,963
-102,413
| -53% | -$6.72M |
|
797
Boston Scientific
BSX
$74.2B
| $5.2M | 0.01% |
139,933
+5,386
| +4% | +$219K |
|
798
Sociedad Química y Minera de Chile
SQM
$20.6B
| $5.19M | 0.01% |
62,178
+50,865
| +450% | +$4.48M |
|
799
Marvell Technology
MRVL
$191B
| $5.19M | 0.01% |
121,097
+49,438
| +69% | +$2.8M |
|
800
Campbell Soup
CPB
$6.78B
| $5.05M | 0.01% |
105,070
-74,082
| -41% | -$3.49M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.